CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
The study, published in The Lancet Haematology, has revealed that the injection had a 73% response rate among Indian patients ...
Q4 2024 Earnings Call Transcript March 18, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...
A 36-year-old woman from New Zealand is being treated for cancer in Shanghai after around 3,000 people donated money to ...
ZME Science on MSN22m
Finally, mRNA vaccines against cancer are starting to become a realityRNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.
Our Bureau, Bengaluru Wednesday, March 19, 2025, 13:15 Hrs [IST] ...
TwoStep Therapeutics Unveils Its Lead Tumor-Targeted Drug Conjugate and New Radiopharmaceutical Program at Debut Scientific ...
Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market. TAIPEI, Taiwan, March 19, 2025 (GLOBE ...
Oxford BioTherapeutics (OBT) has lined up another big pharma partner for its drug discovery platform, agreeing to work with ...
Cancer isn’t just one disease, but many — each with its own challenges, characteristics, risks and treatments. As we have worked tirelessly to understand this group of diseases, I’ve witnessed a ...
Pioneering the World's 1st Dark Matter Cancer Immunotherapy UbiVac's DPV-001 is the World's 1st Dark Matter Cancer Immunotherapy in the Cli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback